Navigation Links
Pharmaceutical Litigation Teleconference Feb. 23
Date:2/3/2009

PHILADELPHIA, Feb. 3 /PRNewswire/ -- HB Litigation Conferences LLC, formerly Mealey's Conferences, is hosting a CLE-accredited teleconference entitled "Hot Topics in Pharmaceutical Litigation 2009" on Feb. 23 at 2 p.m. Eastern Time.

The program will focus on the following products: Byetta, Trasvaginal Surgical Mesh Patch, Digitek, Yasmin birth control pills and NuvaRing.

Topics include: Product backgrounds; product liability overviews; updates on case filings; the alleged injuries; medical evidence; and multi-district litigation.

Attorney Vance Andrus of Andrus-Boudreux PLC of Lafayette, Louisiana and Denver is moderating the 100-minute call. On the panel are J. Paul Sizemore of Girardi Keese in Los Angeles, Donald A. Migliori of Motley Rice LLC in Providence, R.I., Fred Thompson III of Motley Rice in Mount Pleasant, S.C., Lowell W. Finson of Phillips & Associates in Phoenix and Thomas A. Clark of Andrus-Boudreaux in Lafayette, La.

Liability issues surrounding Byetta, Trasvaginal Surgical Mesh Patch, Digitek, Yasmin birth control pills and NuvaRing are the most urgent for plaintiff and defense attorneys practicing in the drug and medical device litigation arena.

For more information contact HB Litigation Conferences at (484) 324-2755 or email the company at info@litigationconferences.com. This product liability teleconference, as are all HB teleconferences, will be taped for people who cannot attend.

HB Litigation Conferences LLC, formerly Mealey's Conferences, is a leading provider of legal education conferences, teleconferences and multimedia content covering insurance, reinsurance, toxic torts, products liability, construction defects, and complex commercial and financial litigation. It is an independent provider whose goal is to create premium networking and educational events for attorneys and executives.

HB Litigation Conferences. Promoting legal discourse since 1992.

    Contact
    Sharon Boothe, Vice President
    Phone: (484) 324-2755 x208
    Email:  sharon.boothe@litigationconferences.com
    Web:    www.LitigationConferences.com


'/>"/>
SOURCE HB Litigation Conferences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
2. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
3. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. West Pharmaceutical Services To Present at the 2009 UBS Global Healthcare Services Conference
6. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
7. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
8. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
9. Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter
10. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
11. Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: